Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy [Phase 2]
A Phase 2 clinical trial evaluating intratumoral chemotherapy delivered through a flexible bronchoscope as an adjunct to brachytherapy for n…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma [Phase 2]
Phase 2 study of AVE0005 (aflibercept) in platinum- and erlotinib-resistant locally advanced or metastatic non-small-cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy [Phase 2]
This Phase 2 trial investigates sequencing or combination of chemotherapy with EGFR-TKIs in non-small cell lung cancer patients who failed p…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase I/II safety study of IPI-504 (retaspimycin hydrochloride), an HSP90 inhibitor, in relapsed/refractory stage IIIb or stage IV non-small…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations [Phase 2]
A Phase 2 trial comparing pemetrexed with gefitinib in locally advanced or metastatic non-small cell lung cancer patients who have previousl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 clinical trial evaluating vandetanib with carboplatin and paclitaxel for resectable stage I–III non-small cell lung cancer was ter…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
A terminated Stanford trial assessed whether real-time Cine-MRI could feasibly guide treatment of moving and deforming tumors in pancreatic …
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial comparing two sequencing regimens for non-small cell lung cancer: docetaxel plus cisplatin followed by gemcitabine versus ge…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating zoledronic acid (Zometa) as adjuvant treatment for malignant pleural effusion due to non-small cell lung cancer was…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase II study evaluating the combination of docetaxel and gefitinib (ZD1839) in elderly patients with non-small cell lung cancer; results o…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating sorafenib in patients with refractory non-small cell lung cancer has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating pemetrexed with either carboplatin or cisplatin plus radiation therapy followed by pemetrexed in patients with …
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 results for Tarceva (erlotinib) in untreated, good-prognosis patients with advanced non-small cell lung cancer have been posted. The…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 pilot study evaluated preoperative Erlotinib (Tarceva) in patients with stages I/II non-small cell lung cancer; results have been …
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and cetuximab in patients with unresectable advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update examining pemetrexed and gemcitabine in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating preoperative therapy in patients with stages I to IIIA (and selected IIIB) non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) [Phase 1]
This ClinicalTrials.gov update reports a Phase 1 study evaluating the IGF-1R inhibitor AXL1717 in combination with gemcitabine and carboplat…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy [Phase 3]
Phase 3 study of pegylated rhG-CSF as support for advanced non-small cell lung cancer patients undergoing chemotherapy; trial status is curr…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating the combination of paclitaxel, carboplatin, and cetuximab in stage IIIB or stage IV non-small cell …
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients [Phase 2]
Phase 2 trial comparing docetaxel- and gemcitabine-based chemotherapy in East Asian and Caucasian patients with non-small cell lung cancer o…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study S0526 evaluated pemetrexed disodium in patients with stage III or stage IV non-small cell lung cancer. The trial was terminate…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates [NA]
This document reports a terminated neoadjuvant trial of gefitinib (IRESSA) as a single-agent preoperative therapy for non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment [Phase 2]
Phase 2 trial evaluating the combination of erlotinib and docetaxel as first-line therapy for selected non-small cell lung cancer patients h…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating combined modality therapy with growth factor support in unresectable loca…